Company Filing History:
Years Active: 2002-2003
Title: Elizabeth R Jacobs: Innovator in 20-HETE Research
Introduction
Elizabeth R Jacobs is a prominent inventor based in Milwaukee, WI, known for her contributions to the field of pharmacology through her innovative research and patents. With a total of three patents to her name, she has established herself as an influential figure in the development of therapeutic applications involving 20-HETE agonists and antagonists.
Latest Patents
Jacobs’ latest patents focus on the disclosure of 20-HETE agonists and antagonists along with their therapeutic applications. In her inventions, the preferred forms of 20-HETE agonists include compounds such as 21-hydroxyheneicosa-5(Z), 8(Z), 11(Z), 14(Z)-tetraenoic acid, 20-hydroxyeicosa-5(Z), 14(Z)-dienoic acid, and 20-, 21-dimethyl 20-HETE. Additionally, her preferred 20-HETE antagonists comprise 5(S)-HETE, 15(S)-HETE, 19(S)-HETE, 19-hydroxynonadeca-5(Z), 8(Z), 11(Z), 14(Z)-tetraenoic acid, and 20-hydroxyeicosa 6(Z), 15(Z)-dienoic acid. These contributions have significant implications for therapeutic advancements in medical science.
Career Highlights
Elizabeth R Jacobs is associated with the MCW Research Foundation, Inc., where she has been pivotal in advancing research related to her patents. Her work at this institution has reinforced her reputation as an expert in her field, especially pertaining to the therapeutic uses of 20-HETE compounds.
Collaborations
Throughout her career, Jacobs has collaborated with esteemed colleagues such as Richard J Roman and John Russell Falck. These collaborations have contributed to her innovative research and have strengthened the impact of her work in the scientific community.
Conclusion
Elizabeth R Jacobs continues to be a trailblazer in her field, applying her expertise to develop novel therapeutic solutions through her research on 20-HETE agonists and antagonists. Her ongoing efforts contribute significantly to the medical and scientific communities, showcasing her dedication to innovation and advancement in pharmacological therapies.